US EditionThe Funds Axon and Eoniq Enter the Sevillian Biotech Neuron STX
Summary by diariodesevilla.es
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
All
Left
Center
Right
Diario de Cádiz+2 Reposted by 2 other sources
This 'spin off' of the University Pablo de Olavide will allocate the million euros of the capital increase for clinical trials in patients of its drug ONESTX-1 New advances to treat Alzheimer's from Seville
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
